Theranostic Platforms Proposed for Cancerous Stem Cells: A Review

Area of Science:

• Oncology
• Biomedical Engineering
• Materials Science

Background:

• Cancer remains a leading global cause of mortality, with conventional therapies often failing due to treatment resistance and tumor recurrence.
• Cancer stem cells (CSCs) are recognized as the primary drivers of tumor proliferation, metastasis, and relapse, evading standard treatments.
• Eradicating CSCs is essential for achieving complete cancer remission and preventing disease progression.

Purpose of the Study:

• To review current therapeutic and diagnostic techniques for targeting cancer stem cells.
• To highlight the importance of understanding CSC mechanisms for developing effective cancer eradication strategies.
• To explore the potential of smart theranostic platforms in simultaneously diagnosing and treating cancers driven by CSCs.

Main Methods:

• Comprehensive literature review of existing research on cancer stem cells, their role in cancer progression, and therapeutic strategies.
• Analysis of various diagnostic and therapeutic modalities designed to target CSCs.
• Discussion of smart materials and theranostic platforms engineered for cancer detection and treatment.

Main Results:

• Conventional therapies are insufficient for eliminating CSCs, contributing to cancer recurrence.
• Theranostic platforms offer a promising approach for integrated cancer diagnosis and treatment.
• Targeting CSCs requires precise knowledge of their biological mechanisms.

Conclusions:

• Understanding cancer stem cell biology is paramount for developing next-generation cancer therapies.
• Designing advanced theranostic platforms is a critical step towards effective cancer eradication.
• Further research into CSC-targeting strategies is needed to improve patient outcomes.